For instance, RBM15 is highly expressed in HCC, and its up-regulation is indicative of undesirable survival outcomes as well as triggers HCC progression by modulating m6A-modified YES1 depending upon IGF2BP1 [45]. The gene discussed is IGF2BP1; the disease is hepatocellular carcinoma.